This seminar brings together industry experts to explore the transformative role of Next Generation Sequencing (NGS) in biopharmaceutical quality control and genetic characterization. The session opens with a focused discussion on advancing contamination control through GMP ready NGS workflows, highlighting how regulatory shifts—including ICH Q5A(R2)—are driving the adoption of NGS for viral safety and microbial detection in manufacturing environments.
Building on this foundation, the seminar delves into the optimization of genetic characterization using NGS, covering applications from cell line authentication to vector integrity and genetic stability assessment. Attendees will gain practical insights into implementing NGS across the product lifecycle, from early development to QC release, while navigating the evolving regulatory landscape and validation expectations.
This NGS seminar is delivered in collaboration with Life Sciences Queensland (LSQ).
Why Attend?
info@wilam.comAn initiative ofBioMelbourne NetworkLevel 6, HWT Tower40 City RoadSouthbank, VIC 3006
Wilam means home in the Woi-wurrung language of the Wurundjeri People of the Kulin Nation, the Traditional Owners of the lands on which we are based.We respectfully acknowledge the Traditional Custodians of the unceded lands and waters of Victoria, the Bunurong, Eastern Maar, Gunaikurnai, Wadawurrung and Wurundjeri Woi-wurrung peoples, on which we live and work. We pay respect to their Elders past and present. We acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector. We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.